To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene YME1L1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
371 representative clones for gene YME1L1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_139312.1   .a 1 to 4025 1 to 4025 exact RefSeq, AAA   4025/4025
(100 %)
1 diff
(100.0 %id)
AL701387 human skeletal muscle .a 8 to 537 1 to 529   tiling clone,   529/529
(100 %)
7 diff
(98.7 %id)
AL702056 human skeletal muscle .a 12 to 604 1 to 592       592/592
(100 %)
2 diff
(99.7 %id)
DA489399 brain .a 13 to 573 2 to 562   tiling clone, capped   561/561
(100 %)
0 diff
(100 %id)
CN481050 eye .a 13 to 606 1 to 594       594/594
(100 %)
1 diff
(99.9 %id)
DA428741 colon .a 14 to 507 2 to 495   capped   494/494
(100 %)
0 diff
(100 %id)
DA437577 tongue, tumor tissue .a 22 to 593 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
CN301568 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 26 to 792 1 to 767   tiling clone,   767/767
(100 %)
5 diff
(99.4 %id)
DN996900 breast cancer, Mammary gland (cancer tissue) .a 29 to 597 1 to 569       569/569
(100 %)
5 diff
(99.2 %id)
DA458696 tongue, tumor tissue .a 42 to 521 2 to 481   capped   480/480
(100 %)
3 diff
(99.4 %id)
BQ423781 melanotic melanoma, skin .a 43 to 886 1 to 846   tiling clone,   846/901
(93 %)
11 diff
(98.8 %id)
AF151782   .a 155 to 4008 1 to 3882 F2R S5R S6A T7R V8R ...     3882/3882
(100 %)
16 diff
(99.6 %id)
DA244976 brain .b 1 to 585 2 to 586   tiling clone, capped   585/585
(100 %)
0 diff
(100 %id)
CV575471 cornea, eye .b 20 to 639 1 to 620       620/620
(100 %)
0 diff
(100 %id)
AJ132637   .b 21 to 3875 1 to 3858 exact tiling clone, AAA   3858/3858
(100 %)
10 diff
(99.8 %id)
DA114252 cerebellum .b 21 to 590 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
NM_014263.2   .b 22 to 3875 1 to 3854 exact RefSeq, AAA   3854/3854
(100 %)
0 diff
(100 %id)
AL708518 human skeletal muscle .b 25 to 682 1 to 658       658/658
(100 %)
0 diff
(100 %id)
DB227821 trachea .b 26 to 588 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA056483 cerebellum .b 27 to 626 2 to 601   capped   600/600
(100 %)
0 diff
(100 %id)
BU188199 melanotic melanoma, skin .b 29 to 848 1 to 820       820/827
(99 %)
4 diff
(99.6 %id)
BX509109   .b 30 to 744 1 to 714       714/715
(99 %)
2 diff
(99.8 %id)
DA947131 Spleen .b 30 to 584 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA008969 adrenal gland .b 31 to 588 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA069553 cerebellum .b 31 to 601 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA114682 cerebellum .b 31 to 588 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA302236 hippocampus .b 31 to 596 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA409605 thalamus .b 31 to 592 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA441518 tongue, tumor tissue .b 31 to 611 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
AL709289 human skeletal muscle .b 31 to 632 1 to 602       602/602
(100 %)
0 diff
(100 %id)
DA522647 brain .b 31 to 594 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA552912   .b 31 to 588 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BU147084 dorsal root ganglia .b 31 to 860 1 to 838       838/884
(94 %)
16 diff
(98.2 %id)
DA721643   .b 31 to 590 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA756949   .b 31 to 607 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA875701 Prostate .b 31 to 593 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA907027   .b 31 to 593 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DB055022 testis .b 31 to 608 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DB092450 testis .b 31 to 583 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DB097196 testis .b 31 to 615 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DB149467 thymus .b 31 to 588 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA480233   .b 33 to 588 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA507158 brain .b 33 to 596 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB225642 trachea .b 33 to 588 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BM787580 stomach .b 34 to 711 1 to 678       678/678
(100 %)
0 diff
(100 %id)
DA297364 hippocampus .b 35 to 615 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA557035   .b 35 to 606 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA597721   .b 35 to 584 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA625693 Kidney .b 35 to 592 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA757673   .b 35 to 604 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA911628   .b 35 to 584 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DB259382 uterus .b 35 to 614 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA573928   .b 37 to 604 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
CX757369 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 37 to 807 1 to 771     Submitted on the opposite strand 771/774
(99 %)
2 diff
(99.8 %id)
DA721592   .b 38 to 602 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
CX867140 embryonic stem .b 39 to 850 1 to 812     Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 812/812
(100 %)
0 diff
(100 %id)
DA952491 Spleen .b 40 to 611 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA234281 brain .b 41 to 613 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA529641 brain .b 41 to 648 2 to 609   capped   608/610
(99 %)
1 diff
(99.9 %id)
DA748160   .b 41 to 599 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA814903   .b 41 to 620 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA816555   .b 41 to 604 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA915012   .b 41 to 594 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB132170 thymus .b 41 to 610 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB238416 trachea .b 41 to 643 2 to 604   capped   603/603
(100 %)
0 diff
(100 %id)
DA165251 amygdala .b 42 to 611 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB083968 testis .b 42 to 594 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA103852 cerebellum .b 43 to 598 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA114274 cerebellum .b 43 to 605 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA175861 amygdala .b 43 to 608 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA196359 amygdala .b 43 to 613 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA351727 substantia nigra .b 43 to 598 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA394014 thalamus .b 43 to 633 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
DA396812 thalamus .b 43 to 641 2 to 600   capped   599/599
(100 %)
0 diff
(100 %id)
DA415926 thalamus .b 43 to 605 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA444077 tongue, tumor tissue .b 43 to 615 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA656424   .b 43 to 613 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA726195   .b 43 to 601 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA762945 tongue .b 43 to 613 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA800040 brain .b 43 to 598 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA885889   .b 43 to 599 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA905892   .b 43 to 614 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DB039594 testis .b 43 to 605 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DB086286 testis .b 43 to 596 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB105512 thymus .b 43 to 618 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DB110455 thymus .b 43 to 618 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DB141045 thymus .b 43 to 599 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB154131 thymus .b 43 to 635 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
DB199138 trachea .b 43 to 599 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB224179 trachea .b 43 to 612 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB256393 uterus .b 43 to 612 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB275788 uterus .b 43 to 607 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB292303 uterus .b 43 to 615 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA274374 corpus callosum .b 44 to 609 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA954119 Spleen .b 45 to 617 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA207509 brain .b 46 to 625 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA300849 hippocampus .b 46 to 616 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA440196 tongue, tumor tissue .b 46 to 617 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA506968 brain .b 46 to 602 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA711941   .b 46 to 607 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA748029   .b 46 to 607 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA497361 brain .b 47 to 613 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BM468415 melanotic melanoma, skin .b 47 to 988 1 to 944       944/987
(95 %)
11 diff
(98.9 %id)
BI830135 brain, medulla .b 49 to 778 1 to 730       730/730
(100 %)
0 diff
(100 %id)
DA959681 Spleen .b 50 to 602 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
BC023507 Placenta, choriocarcinoma .b 52 to 3257 1 to 3206 exact available from MGC, AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 3206/3206
(100 %)
1 diff
(100.0 %id)
CN301561 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 52 to 728 1 to 677       677/677
(100 %)
0 diff
(100 %id)
BX426567 T cells (Jurkat cell line) .b 52 to 1062 1 to 1002       1002/1003
(99 %)
15 diff
(98.6 %id)
BP872267 embryonal kidney .b 52 to 629 1 to 578       578/578
(100 %)
0 diff
(100 %id)
DA439108 tongue, tumor tissue .b 55 to 607 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA448937 tongue, tumor tissue .b 55 to 605 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BM556685 duodenal adenocarcinoma, cell line, small intestine .b 57 to 895 1 to 848       848/997
(85 %)
25 diff
(97.5 %id)
BQ070362 brain, neuroblastoma, cell line .b 57 to 1062 1 to 1017       1017/1018
(99 %)
35 diff
(96.6 %id)
BU155006 melanotic melanoma, skin .b 58 to 873 1 to 830       830/896
(92 %)
17 diff
(98.2 %id)
DA475260   .b 60 to 620 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DB016526 esophageal, tumor tissue .b 61 to 627 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB249650 uterus .b 61 to 614 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
BG120678 adenocarcinoma, cell line, Liver .b 62 to 886 1 to 817       817/885
(92 %)
34 diff
(96.2 %id)
AK291292 tongue .b 65 to 2586 1 to 2522 T25I     2522/2522
(100 %)
2 diff
(100.0 %id)
DA012218 adrenal gland .b 66 to 633 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
AK314372   .b 66 to 2354 1 to 2289 exact     2289/2289
(100 %)
0 diff
(100 %id)
DA239478 brain .b 66 to 656 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
DA451959 tongue, tumor tissue .b 66 to 629 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA453520 tongue, tumor tissue .b 66 to 635 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA458585 tongue, tumor tissue .b 66 to 642 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA458903 tongue, tumor tissue .b 66 to 630 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA479595   .b 66 to 617 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA549900   .b 66 to 642 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA573354   .b 66 to 894 2 to 826   capped   825/849
(97 %)
13 diff
(98.5 %id)
DA578474   .b 66 to 631 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA642820 Liver .b 66 to 631 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA679590   .b 66 to 629 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA706703   .b 66 to 641 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA725734   .b 66 to 626 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA726528   .b 66 to 620 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA925732 small intestine .b 66 to 651 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DB021354 testis .b 66 to 635 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB089918 testis .b 66 to 628 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DB159536 thymus .b 66 to 658 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
CN301536 embryonic stem cells, cell lines H1, H7, andH9 .b 67 to 698 1 to 632       632/632
(100 %)
0 diff
(100 %id)
DA720357   .b 67 to 640 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB100083 testis .b 67 to 658 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
DB165727 thymus .b 67 to 639 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
AY358484   .b 68 to 2592 1 to 2525 exact AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2525/2525
(100 %)
1 diff
(100.0 %id)
BX472489   .b 69 to 645 1 to 577       577/577
(100 %)
0 diff
(100 %id)
DA654751   .b 71 to 635 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB259898 uterus .b 72 to 648 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA738427   .b 73 to 894 2 to 820   capped   819/856
(95 %)
14 diff
(98.4 %id)
BQ425509 leiomyosarcoma, uterus .b 74 to 946 1 to 878       878/878
(100 %)
12 diff
(98.7 %id)
BX406565 fetal liver, Liver .b 77 to 371 1 to 295       295/295
(100 %)
0 diff
(100 %id)
BQ224171 embryonal carcinoma, cell line, testis .b 80 to 915 1 to 842       840/842
(99 %)
10 diff
(98.9 %id)
DB123820 thymus .b 82 to 672 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
BG686160 B-cells, primary B-cells from tonsils (cell line) .b 85 to 759 1 to 675       675/678
(99 %)
2 diff
(99.8 %id)
BX425858 neuroblastoma .b 89 to 1153 1 to 1060       1060/1060
(100 %)
7 diff
(99.4 %id)
BM471360 melanotic melanoma, skin .b 112 to 1098 1 to 990       988/990
(99 %)
15 diff
(98.5 %id)
DB089229 testis .b 114 to 675 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BQ437066 melanotic melanoma, skin .b 115 to 974 1 to 868       866/871
(99 %)
13 diff
(98.6 %id)
CN301558 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 117 to 740 1 to 624       624/624
(100 %)
0 diff
(100 %id)
CN301570 embryonic stem cells, cell lines H1, H7, andH9 .b 117 to 829 1 to 713       713/713
(100 %)
0 diff
(100 %id)
DR761953 embryonic stem .b 207 to 1029 1 to 823       823/823
(100 %)
0 diff
(100 %id)
CB215705 normal endometrium, late proliferativephase, cycle day 13, uterus .b 280 to 891 1 to 612       612/612
(100 %)
0 diff
(100 %id)
BU169709 embryonal carcinoma, cell line, testis .b 294 to 1166 1 to 881       881/883
(99 %)
14 diff
(98.5 %id)
DB101677 thymus .b 369 to 941 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BF793595 adrenal cortex carcinoma, cell line, adrenal gland .b 399 to 1157 1 to 752       752/931
(80 %)
16 diff
(98.3 %id)
CV573365 cornea, eye .b 455 to 1066 1 to 612       612/612
(100 %)
0 diff
(100 %id)
AL559492 T cells from T cell leukemia .b 534 to 1386 1 to 853       853/853
(100 %)
0 diff
(100 %id)
DB245697 uterus, tumor tissue .b 550 to 1113 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA666879   .b 640 to 1201 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA484910 brain .b 655 to 1221 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
AF070656   .b 678 to 2596 1 to 1917       1917/1922
(99 %)
4 diff
(99.8 %id)
AL701219 human skeletal muscle .b 736 to 1349 1 to 615       615/615
(100 %)
1 diff
(99.9 %id)
DA546162   .b 827 to 1384 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA084438 cerebellum .b 835 to 1391 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA577698   .b 843 to 1405 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA023843   .b 880 to 1452 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DB261193 uterus .b 892 to 1453 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA021038   .b 897 to 1479 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
BI856907 breast, mammary adenocarcinoma, cell line .b 911 to 1541 1 to 631       631/631
(100 %)
1 diff
(99.9 %id)
BG254700 adenocarcinoma, cell line, Prostate .b 917 to 1708 1 to 792       792/874
(90 %)
23 diff
(97.4 %id)
DA751602   .b 1061 to 1614 9 to 562   capped   554/561
(98 %)
6 diff
(99.0 %id)
DA888685   .b 1079 to 1643 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB180527 kidney, tumor tissue .b 1093 to 1647 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BQ717013 sympathetic trunk .b 1141 to 1977 1 to 845       843/882
(95 %)
15 diff
(98.3 %id)
DA690321   .b 1157 to 1739 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
AK001259   .b 1232 to 3257 1 to 2024   available from FLJ,   2024/2024
(100 %)
5 diff
(99.8 %id)
DA273943 corpus callosum .b 1232 to 1797 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DB111621 thymus .b 1263 to 1826 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BM756343 Ascites, stomach .b 1304 to 1989 1 to 686       686/686
(100 %)
0 diff
(100 %id)
BM768047 Ascites, stomach .b 1304 to 1974 1 to 671       671/671
(100 %)
0 diff
(100 %id)
BM770338 Ascites, stomach .b 1304 to 1903 1 to 600       600/600
(100 %)
0 diff
(100 %id)
DA600258   .b 1343 to 1898 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
CB161024 Liver .b 1447 to 2081 1 to 635       635/635
(100 %)
0 diff
(100 %id)
BQ940003 leiomyosarcoma, uterus .b 1481 to 2343 1 to 866       866/867
(99 %)
4 diff
(99.6 %id)
CX784086 human embryonic stem cells .b 1552 to 2264 1 to 713       713/713
(100 %)
0 diff
(100 %id)
BX426566 T cells (Jurkat cell line) .b 1606 to 2564 957 to 1       957/1045
(91 %)
15 diff
(98.6 %id)
TI_149303055   .b 1646 to 2592 1013 to 84   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 930/976
(95 %)
26 diff
(97.4 %id)
TI_149302702   .b 1709 to 2592 933 to 58   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 876/970
(90 %)
16 diff
(98.4 %id)
CR987210 T-Lymphocytes .b 1713 to 2644 1 to 926       926/949
(97 %)
10 diff
(99.0 %id)
CB119538 Liver .b 1719 to 2305 1 to 587       587/587
(100 %)
0 diff
(100 %id)
CN301537 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1738 to 2488 1 to 751       751/751
(100 %)
1 diff
(99.9 %id)
BM761552 myeloma .b 1738 to 2310 1 to 573       573/573
(100 %)
0 diff
(100 %id)
TI_154108360   .b 1770 to 2592 903 to 83   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 821/945
(86 %)
6 diff
(99.4 %id)
AA452392   .b 1776 to 2241 1 to 466   fully sequenced,   466/466
(100 %)
0 diff
(100 %id)
CA447519 Chondrosarcoma, Left Pelvis .b 1814 to 2592 796 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 778/778
(100 %)
4 diff
(99.5 %id)
BM981137 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 1815 to 2592 796 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 778/778
(100 %)
1 diff
(99.9 %id)
BM980852 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 1942 to 2592 667 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 649/649
(100 %)
1 diff
(99.9 %id)
AW138746   .b 2012 to 2597 603 to 18   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 586/586
(100 %)
0 diff
(100 %id)
CX867059 embryonic stem .b 2102 to 2774 699 to 27   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 673/673
(100 %)
2 diff
(99.8 %id)
AA452161   .b 2180 to 2596 417 to 1   fully sequenced,   417/417
(100 %)
1 diff
(99.8 %id)
AW955309   .b 2493 to 3203 1 to 711       711/716
(99 %)
14 diff
(98.1 %id)
CN301534 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 2496 to 3164 1 to 669       669/669
(100 %)
1 diff
(99.9 %id)
AU138715 placenta .b 2633 to 3286 2 to 658   capped   657/657
(100 %)
4 diff
(99.4 %id)
BM995282 Chondrosarcoma, Left Pubic Bone .b 2661 to 3257 614 to 19   AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 596/599
(99 %)
2 diff
(99.7 %id)
AI904692 breast .b 2731 to 2888 1 to 158       158/159
(99 %)
1 diff
(99.4 %id)
EH323327   .b 2751 to 2829 1 to 78       78/78
(100 %)
1 diff
(98.8 %id)
AI982808 adenocarcinoma, Pancreas .b 2771 to 3257 489 to 1       489/489
(100 %)
4 diff
(99.2 %id)
CA310172 Alveolar Macrophage, lung .b 2775 to 3586 829 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 811/811
(100 %)
1 diff
(99.9 %id)
CN301553 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2815 to 3563 1 to 750       750/750
(100 %)
6 diff
(99.2 %id)
CD638804 pooled .b 2826 to 3425 1 to 602       602/602
(100 %)
6 diff
(99.1 %id)
BG497396 lung, mucoepidermoid carcinoma .b 2838 to 3454 1 to 620       620/925
(67 %)
6 diff
(99.4 %id)
AW963623   .b 2848 to 3585 1 to 739       739/742
(99 %)
9 diff
(98.8 %id)
BQ019457 Chondrosarcoma, Left Pubic Bone .b 2848 to 3480 649 to 17   AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 633/633
(100 %)
5 diff
(99.3 %id)
BQ019826 Chondrosarcoma, Left Pubic Bone .b 2911 to 3480 586 to 17   AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 570/570
(100 %)
0 diff
(100 %id)
CN301542 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2950 to 3617 1 to 668       668/668
(100 %)
0 diff
(100 %id)
BM996317 lung, Metastatic Chondrosarcoma .b 2955 to 3592 657 to 19   AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 639/639
(100 %)
1 diff
(99.9 %id)
TI_154101543   .b 3047 to 3875 903 to 85   AAA   819/819
(100 %)
30 diff
(96.4 %id)
TI_149271501   .b 3091 to 3875 862 to 86   AAA   777/944
(82 %)
26 diff
(97.3 %id)
BX485956   .b 3102 to 3875 821 to 47   AAA Submitted on the opposite strand 775/775
(100 %)
1 diff
(99.9 %id)
BQ230570 melanotic melanoma, skin .b 3124 to 3874 1 to 753       753/936
(80 %)
3 diff
(99.7 %id)
BM798155 Ascites, stomach .b 3128 to 3694 1 to 567       567/567
(100 %)
0 diff
(100 %id)
CA306353 Alveolar Macrophage, lung .b 3158 to 3875 733 to 16   AAA   718/718
(100 %)
0 diff
(100 %id)
TI_154130307   .b 3167 to 3875 816 to 107   AAA   710/964
(73 %)
7 diff
(99.3 %id)
EL951084 eyeball .b 3186 to 3681 1 to 495       495/495
(100 %)
4 diff
(99.2 %id)
CA426140 Bone, Subchondral Bone .b 3186 to 3875 710 to 19   AAA   692/692
(100 %)
2 diff
(99.8 %id)
BF878409 lung_tumor .b 3190 to 3700 539 to 27     Submitted on the opposite strand 513/539
(95 %)
0 diff
(100 %id)
TI_149306001   .b 3200 to 3872 761 to 87   AAA   675/903
(74 %)
3 diff
(99.7 %id)
BU686181 lung, Primary Lung Epithelial Cells .b 3200 to 3872 693 to 19   AAA   675/688
(98 %)
3 diff
(99.6 %id)
AA989107 carcinoid, lung .b 3282 to 3587 307 to 2       306/307
(99 %)
0 diff
(100 %id)
DB378664 placenta .b 3289 to 3871 583 to 6       578/586
(98 %)
0 diff
(100 %id)
C06118   .b 3319 to 3877 565 to 6       560/565
(99 %)
0 diff
(100 %id)
AA513735 breast .b 3381 to 3875 495 to 1       495/495
(100 %)
0 diff
(100 %id)
CF130197 Chondrosarcoma Lung Metastasis cell lines, lung .b 3383 to 3875 1 to 493   AAA   493/493
(100 %)
0 diff
(100 %id)
TI_154192138   .b 3383 to 3875 48 to 540   AAA   493/493
(100 %)
0 diff
(100 %id)
AI301983 carcinoid, lung .b 3402 to 3587 187 to 2       186/187
(99 %)
0 diff
(100 %id)
BQ027106 Chondrosarcoma, Left Pubic Bone .b 3459 to 4150 710 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 692/692
(100 %)
1 diff
(99.9 %id)
AA075084   .b 3461 to 3875 427 to 12   AAA Submitted on the opposite strand 416/417
(99 %)
2 diff
(99.6 %id)
TI_149289532   .b 3495 to 3871 66 to 441     Submitted on the opposite strand 376/1080
(34 %)
5 diff
(99.6 %id)
BU681680 lung .b 3496 to 3871 1 to 376   AAA Submitted on the opposite strand 376/384
(97 %)
7 diff
(98.2 %id)
BX406564 fetal liver, Liver .b 3506 to 3831 326 to 1       326/326
(100 %)
3 diff
(99.1 %id)
GD146261   .b 3744 to 3877 1 to 134       134/139
(96 %)
3 diff
(97.9 %id)
GD152427   .b 3747 to 3872 1 to 126   AAA   126/126
(100 %)
2 diff
(98.5 %id)
GD152491   .b 3747 to 3882 1 to 137       137/145
(94 %)
7 diff
(95.2 %id)
DC363275   .c 1 to 543 7 to 550   tiling clone,   550/550
(100 %)
3 diff
(99.5 %id)
AK297973   .c 10 to 2478 1 to 2469 exact tiling clone,   2469/2469
(100 %)
1 diff
(100.0 %id)
DC352271 brain .c 10 to 662 1 to 656       656/757
(86 %)
9 diff
(98.9 %id)
DC357980   .c 10 to 558 1 to 549       549/549
(100 %)
0 diff
(100 %id)
DC368264   .c 10 to 576 1 to 569       569/569
(100 %)
2 diff
(99.7 %id)
DC364742   .c 17 to 566 1 to 550       550/550
(100 %)
1 diff
(99.9 %id)
DC329620 corpus callosum .c 20 to 598 1 to 579       579/579
(100 %)
0 diff
(100 %id)
DC371673   .c 20 to 566 1 to 547       547/547
(100 %)
0 diff
(100 %id)
DC324055 brain .c 22 to 617 1 to 596       596/596
(100 %)
0 diff
(100 %id)
DC342790 thalamus .c 22 to 569 1 to 548       548/548
(100 %)
0 diff
(100 %id)
DC383386 Prostate .c 22 to 558 1 to 537       537/537
(100 %)
0 diff
(100 %id)
DC379006 pericardium .c 25 to 603 1 to 579       579/579
(100 %)
0 diff
(100 %id)
DC299654   .c 40 to 603 1 to 564       564/564
(100 %)
2 diff
(99.7 %id)
DC369386   .c 40 to 617 1 to 578       578/578
(100 %)
0 diff
(100 %id)
DC332315 hippocampus .c 41 to 577 1 to 537       537/537
(100 %)
0 diff
(100 %id)
DC363326   .c 44 to 578 1 to 537       537/537
(100 %)
5 diff
(99.1 %id)
DC414899 trachea .c 44 to 566 1 to 523       523/523
(100 %)
2 diff
(99.7 %id)
DC422221 uterus .c 44 to 593 1 to 550       550/550
(100 %)
3 diff
(99.5 %id)
DC300087   .c 45 to 613 1 to 569       569/569
(100 %)
1 diff
(99.9 %id)
DC385275   .c 45 to 608 1 to 564       564/564
(100 %)
2 diff
(99.7 %id)
DC404322 testis .c 45 to 615 1 to 571       571/571
(100 %)
1 diff
(99.9 %id)
DC410254 thymus .c 45 to 621 1 to 577       577/577
(100 %)
2 diff
(99.7 %id)
DC422348 uterus .c 45 to 566 1 to 523       523/523
(100 %)
1 diff
(99.9 %id)
DA990721 synovial membrane tissue from rheumatioidarthritis .c 46 to 573 2 to 532   capped   531/531
(100 %)
5 diff
(99.1 %id)
DA990728 synovial membrane tissue from rheumatioidarthritis .c 46 to 568 2 to 527   capped   526/526
(100 %)
5 diff
(99.1 %id)
DC368237   .c 47 to 608 1 to 562       562/562
(100 %)
0 diff
(100 %id)
DC351218 brain .c 360 to 943 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BM016519 breast, mammary adenocarcinoma, cell line .c 470 to 1209 1 to 736   tiling clone,   736/740
(99 %)
5 diff
(99.4 %id)
TI_59394141   .c 470 to 1209 54 to 789       736/740
(99 %)
5 diff
(99.4 %id)
DA235488 brain .d 1 to 594 2 to 595   tiling clone, capped   594/596
(99 %)
1 diff
(99.9 %id)
DA832317 placenta .d 46 to 766 2 to 725   capped   724/725
(99 %)
7 diff
(99.1 %id)
BU156440 eye, retinoblastoma .d 59 to 987 1 to 930   tiling clone,   930/930
(100 %)
19 diff
(98.0 %id)
DB132781 thymus .d 68 to 608 2 to 543   capped   542/542
(100 %)
5 diff
(99.1 %id)
BE613637 leiomyosarcoma, uterus .d 112 to 866 1 to 745   tiling clone,   747/964
(77 %)
19 diff
(98.1 %id)
DN997471 breast cancer, Mammary gland (cancer tissue) .d 173 to 831 1 to 659   tiling clone,   659/659
(100 %)
2 diff
(99.7 %id)
DB378446 placenta .d 1680 to 2228 545 to 1   tiling clone,   545/617
(88 %)
13 diff
(97.9 %id)
F06870 brain, total brain .e 1 to 300 1 to 300   tiling clone,   300/300
(100 %)
0 diff
(100 %id)
F06886 brain, total brain .e 1 to 307 1 to 307   tiling clone,   307/307
(100 %)
2 diff
(99.4 %id)
Z39962 brain, total brain .e 1549 to 1857 309 to 1   tiling clone,   309/316
(97 %)
0 diff
(100 %id)
F03137 brain, total brain .e 1655 to 1857 203 to 1       203/203
(100 %)
0 diff
(100 %id)
CR611030 T cells (Jurkat cell line) Cot10-normalized .f 1 to 1998 1 to 1998 exact tiling clone,   1998/1998
(100 %)
0 diff
(100 %id)
TI_151730360   .g 1 to 595 675 to 83 A19P L71V Q78K N79P Q80V ... tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 593/971
(61 %)
15 diff
(98.5 %id)
DB033769 testis .h 1 to 581 2 to 582 exact tiling clone, capped   581/581
(100 %)
0 diff
(100 %id)
DA018719   .i 1 to 555 2 to 556 exact tiling clone, capped   555/555
(100 %)
1 diff
(99.9 %id)
DA111676 cerebellum .j -11 to 582 2 to 595   capped   594/594
(100 %)
2 diff
(99.7 %id)
DA800286 brain .j -11 to 560 2 to 573   capped   572/574
(99 %)
1 diff
(99.9 %id)
DW458267 Liver .j -10 to 128 18 to 156       139/156
(89 %)
6 diff
(96.2 %id)
AL704773 human skeletal muscle .j -9 to 591 1 to 601   tiling clone,   601/601
(100 %)
2 diff
(99.7 %id)
DW423201 Liver .j -9 to 265 18 to 292       275/292
(94 %)
6 diff
(98.0 %id)
DA507799 brain .j -9 to 562 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DB076381 testis .j -9 to 543 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
AL704757 human skeletal muscle .j 1 to 523 8 to 530       530/530
(100 %)
0 diff
(100 %id)
AK022930   .j 1 to 3021 2 to 3022   tiling clone, available from FLJ,   3022/3022
(100 %)
4 diff
(99.9 %id)
AL706329 human skeletal muscle .j 1 to 604 1 to 603       603/603
(100 %)
2 diff
(99.7 %id)
AU128568   .j 1 to 522 2 to 528   capped   527/527
(100 %)
6 diff
(98.9 %id)
AL712023 human skeletal muscle .j 10 to 687 1 to 678       678/678
(100 %)
4 diff
(99.5 %id)
BX504351   .j 11 to 737 1 to 725       725/725
(100 %)
5 diff
(99.4 %id)
BQ646939 hepatocellular carcinoma, cell line, Liver .j 21 to 693 72 to 750   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 679/754
(90 %)
11 diff
(98.6 %id)
BQ653380 hepatocellular carcinoma, cell line, Liver .j 24 to 638 1 to 616       616/952
(64 %)
14 diff
(98.6 %id)
BQ646392 hepatocellular carcinoma, cell line, Liver .j 24 to 697 1 to 673   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 673/674
(99 %)
4 diff
(99.5 %id)
DA185061 amygdala .j 38 to 574 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
DB074033 testis .j 38 to 595 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
CN306080 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j 41 to 689 1 to 649   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 649/649
(100 %)
1 diff
(99.9 %id)
DA238239 brain .j 43 to 629 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DW414439 Liver .j 67 to 365 18 to 316       299/316
(94 %)
6 diff
(98.2 %id)
DB224585 trachea .j 74 to 605 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DW414238 Liver .j 110 to 418 10 to 317       308/317
(97 %)
6 diff
(98.2 %id)
DW413877 Liver .j 146 to 446 18 to 318       301/318
(94 %)
6 diff
(98.2 %id)
AV735836 cord Blood .j 162 to 693 52 to 585   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 534/586
(91 %)
6 diff
(99.0 %id)
W24314 senescent fibroblast .j 185 to 667 1 to 494   fully sequenced,   494/494
(100 %)
12 diff
(97.6 %id)
F31162 pectoral muscle (after mastectomy) .j 297 to 656 1 to 360       360/360
(100 %)
1 diff
(99.8 %id)
BF911615 uterus_tumor .j 298 to 647 1 to 349       349/349
(100 %)
7 diff
(98.0 %id)
N95271 senescent fibroblast .j 316 to 684 364 to 1   fully sequenced,   364/364
(100 %)
1 diff
(99.8 %id)
F36583 pectoral muscle (after mastectomy) .j 324 to 690 1 to 367   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 367/367
(100 %)
3 diff
(99.2 %id)
DA439065 tongue, tumor tissue .j 465 to 1062 2 to 599   capped   598/598
(100 %)
1 diff
(99.9 %id)
BX497238 Liver .j 883 to 1439 1 to 557       557/557
(100 %)
0 diff
(100 %id)
DA907487   .j 883 to 1441 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB220040 trachea .j 886 to 1445 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA815906   .j 890 to 1457 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
AL710338 human skeletal muscle .j 893 to 1554 1 to 662 S30T tiling clone,   662/662
(100 %)
1 diff
(99.9 %id)
DA693554   .j 895 to 1465 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DB129041 thymus .j 917 to 1470 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA378003 thalamus .j 918 to 1470 2 to 553 S37Q V38F S39L Q40K N41T ... capped   552/552
(100 %)
3 diff
(99.5 %id)
DA686574   .j 925 to 1452 2 to 530   capped   529/529
(100 %)
1 diff
(99.9 %id)
BC019602 Eye, retinoblastoma .j 937 to 3471 1 to 2534   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2534/2534
(100 %)
3 diff
(99.9 %id)
BE618002 eye, retinoblastoma .j 945 to 1523 1 to 581 I76N F77I E78R G79R Y80V ... available from MGC,   581/582
(99 %)
8 diff
(98.7 %id)
BE784678 large cell carcinoma, lung .j 1665 to 2233 1 to 575       575/575
(100 %)
17 diff
(97.1 %id)
BM793392 Ascites, stomach .j 1891 to 2550 1 to 660       660/660
(100 %)
0 diff
(100 %id)
BG027168 Bone, osteosarcoma, cell line .j 2159 to 2850 51 to 735       685/989
(69 %)
42 diff
(95.8 %id)
AU150834   .j 2465 to 3021 554 to 1       554/556
(99 %)
12 diff
(97.9 %id)
DA384929 thalamus .j 2516 to 3088 2 to 572   tiling clone, capped   571/571
(100 %)
2 diff
(99.7 %id)
AA828049 ovary .j 2621 to 3036 421 to 6       416/421
(98 %)
0 diff
(100 %id)
FN160271 breast carcinoma .j 2881 to 2966 1 to 86       86/89
(96 %)
1 diff
(98.9 %id)
AA809990 germinal center B cell .j 3088 to 3478 404 to 14   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 391/391
(100 %)
1 diff
(99.8 %id)
N53511 multiple sclerosis lesions .j 3235 to 3526 296 to 1   tiling clone,   296/413
(71 %)
4 diff
(99.1 %id)
AA639867 colon, colon tumor RER+ .k 1 to 476 485 to -6 R2L K34E S36L A37Q P38G ... tiling clone,   485/485
(100 %)
4 diff
(99.2 %id)
BF000181 colon, colon tumor, RER+ .k 72 to 467 404 to 10   tiling clone,   395/404
(97 %)
1 diff
(99.8 %id)
BX457468 thymus .l 1 to 413 1 to 413 W92X R93X tiling clone,   413/413
(100 %)
5 diff
(98.8 %id)
AW977603   .m-u 1 to 518 522 to 1   tiling clone, Submitted on the opposite strand 522/522
(100 %)
5 diff
(99.1 %id)
AW997043 breast_normal .m-u 6 to 567 566 to 5   tiling clone, Submitted on the opposite strand 562/566
(99 %)
0 diff
(100 %id)
AL699480 human skeletal muscle .m-u 108 to 672 9 to 573       565/565
(100 %)
1 diff
(99.9 %id)
AA814757 germinal center B cell .m-u 157 to 526 376 to 3   tiling clone,   374/376
(99 %)
0 diff
(100 %id)
AA994989 pooled .m-u 184 to 518 339 to 1       339/339
(100 %)
2 diff
(99.5 %id)
DA109534 cerebellum .m-u 486 to 1086 2 to 602 exact tiling clone, to resequence, capped   601/601
(100 %)
2 diff
(99.7 %id)
DA148735 amygdala .m-u 1923 to 2483 2 to 563   tiling clone, capped   562/562
(100 %)
1 diff
(99.9 %id)
BX955564   .m-u 2140 to 2553 414 to 1     Submitted on the opposite strand 414/414
(100 %)
2 diff
(99.6 %id)
DR759803 embryonic stem .m-u 2199 to 2666 1 to 468       468/468
(100 %)
10 diff
(97.9 %id)
AV731531 hypothalamus .m-u 2269 to 2836 563 to 1   tiling clone, Submitted on the opposite strand 563/645
(87 %)
16 diff
(97.6 %id)
AW770803 colon, juvenile granulosa tumor .m-u 2398 to 2811 413 to 1   tiling clone,   413/413
(100 %)
1 diff
(99.8 %id)
DB299789 cerebellum .m-u 2424 to 2786 363 to 1   to resequence,   363/363
(100 %)
0 diff
(100 %id)
DA636298 Kidney .n 1 to 591 2 to 592   tiling clone, capped   591/591
(100 %)
0 diff
(100 %id)
DB176249 kidney, tumor tissue .n 1 to 562 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA686041   .n 11 to 546 2 to 538   capped   537/537
(100 %)
2 diff
(99.7 %id)
DB062819 testis .n 31 to 565 2 to 537   capped   536/536
(100 %)
6 diff
(98.9 %id)
DB012078 esophageal, tumor tissue .n 35 to 592 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA524422 brain .n 36 to 605 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
BM764010 myeloma .n 390 to 1089 1 to 700 exact tiling clone,   700/700
(100 %)
0 diff
(100 %id)
BM839816 myeloma .n 390 to 945 1 to 556 exact     556/556
(100 %)
0 diff
(100 %id)
DA237895 brain .o-u 1 to 584 2 to 584 R2G L12G R13D Q14R G15V ... tiling clone, capped   583/583
(100 %)
3 diff
(99.5 %id)
DB142912 thymus .o-u 516 to 1073 2 to 559   tiling clone, capped   558/558
(100 %)
1 diff
(99.9 %id)
BG618208 Liver .p-u 1 to 743 1 to 743 exact tiling clone,   743/748
(99 %)
7 diff
(99.1 %id)
AW268493 pooled .p-u 559 to 1021 1 to 463   tiling clone, Submitted on the opposite strand 463/463
(100 %)
0 diff
(100 %id)
BG611437 adenocarcinoma, Prostate .q-u 1 to 725 1 to 726 H2I L3C L4G V5T H6F ... tiling clone,   726/726
(100 %)
65 diff
(91.1 %id)
AA707597   .q-u 418 to 851 434 to 1 exact tiling clone,   434/434
(100 %)
2 diff
(99.6 %id)
H95572 liver and spleen .q-u 528 to 876 350 to 1 exact tiling clone,   350/350
(100 %)
1 diff
(99.8 %id)
DA181055 amygdala .r 1 to 555 8 to 562   tiling clone, capped   555/555
(100 %)
1 diff
(99.9 %id)
CD706981 normal nasopharynx .r 451 to 756 50 to 355   tiling clone,   306/355
(86 %)
6 diff
(98.4 %id)
CN301567 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .s 1 to 737 1 to 738 V2S tiling clone,   738/738
(100 %)
3 diff
(99.6 %id)
DB111577 thymus .t 1 to 561 5 to 565 exact tiling clone, capped   564/564
(100 %)
1 diff
(99.9 %id)
DB117664 thymus .u-u 1 to 504 2 to 505 exact tiling clone, capped   504/504
(100 %)
0 diff
(100 %id)
284 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m-u, .n, .o-u, .p-u, .q-u, .r, .s, .t, .u-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI